TONDO, PASQUALE
 Distribuzione geografica
Continente #
NA - Nord America 2.070
AS - Asia 1.463
EU - Europa 1.338
SA - Sud America 320
Continente sconosciuto - Info sul continente non disponibili 265
AF - Africa 35
OC - Oceania 7
Totale 5.498
Nazione #
US - Stati Uniti d'America 1.996
SG - Singapore 594
RU - Federazione Russa 340
IT - Italia 270
BR - Brasile 252
CN - Cina 249
HK - Hong Kong 225
IE - Irlanda 183
VN - Vietnam 173
DE - Germania 127
FR - Francia 124
SE - Svezia 76
FI - Finlandia 59
BD - Bangladesh 56
GB - Regno Unito 44
CA - Canada 40
IN - India 36
NL - Olanda 26
AR - Argentina 25
IQ - Iraq 19
PL - Polonia 16
JP - Giappone 15
MX - Messico 15
TR - Turchia 15
CZ - Repubblica Ceca 13
UA - Ucraina 12
CO - Colombia 11
ID - Indonesia 10
UZ - Uzbekistan 10
EC - Ecuador 9
ES - Italia 9
BE - Belgio 8
CL - Cile 8
JO - Giordania 8
MA - Marocco 8
PK - Pakistan 8
AT - Austria 7
AU - Australia 7
TN - Tunisia 7
SA - Arabia Saudita 6
JM - Giamaica 5
MY - Malesia 5
PH - Filippine 5
PT - Portogallo 5
ZA - Sudafrica 5
KE - Kenya 4
LT - Lituania 4
PY - Paraguay 4
TH - Thailandia 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
NP - Nepal 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
DK - Danimarca 2
HN - Honduras 2
KZ - Kazakistan 2
LB - Libano 2
LY - Libia 2
MK - Macedonia 2
NO - Norvegia 2
OM - Oman 2
RO - Romania 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
VE - Venezuela 2
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DJ - Gibuti 1
GA - Gabon 1
GH - Ghana 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
ML - Mali 1
NI - Nicaragua 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.233
Città #
San Jose 552
Ashburn 266
Singapore 265
Hong Kong 219
Dublin 183
Beijing 124
Dallas 105
Chandler 102
Council Bluffs 96
Columbus 80
Lauterbourg 69
Ho Chi Minh City 65
Nyköping 62
Santa Clara 57
Munich 53
Moscow 39
New York 39
Phoenix 36
Hanoi 34
Los Angeles 34
Frankfurt am Main 31
Helsinki 29
Turku 29
Milan 23
Rome 21
Boardman 20
The Dalles 20
Foggia 18
Naples 18
Toronto 17
Bari 16
Seattle 16
Warsaw 15
Düsseldorf 14
São Paulo 14
Tokyo 14
London 13
Nuremberg 13
Brooklyn 12
Hillsboro 12
Palermo 12
Princeton 12
Atlanta 11
Brno 11
Falkenstein 11
Chicago 10
Montreal 10
Rio de Janeiro 10
Amman 8
Amsterdam 8
Boston 8
Chennai 8
Pune 8
Tashkent 8
Washington 8
Brussels 7
Buffalo 7
Haiphong 7
Istanbul 7
San Francisco 7
Baghdad 6
Florence 6
Mexico City 6
Orem 6
Salvador 6
Stockholm 6
Bologna 5
Denver 5
Fortaleza 5
Guangzhou 5
Hải Dương 5
Miami 5
New Delhi 5
Philadelphia 5
Portsmouth 5
Ankara 4
Brisbane 4
Cincinnati 4
Da Nang 4
Dhaka 4
Guayaquil 4
Kyiv 4
Montevideo 4
Paris 4
Poplar 4
Shanghai 4
Trani 4
Turin 4
Venice 4
Verona 4
Wilmington 4
Wuhan 4
Aldeia de Paio Pires 3
Asunción 3
Baku 3
Bangkok 3
Brasília 3
Buenos Aires 3
Campinas 3
Can Tho 3
Totale 3.196
Nome #
Fisiologia dell'apparato respiratorio 169
Mortality in obstructive sleep apnea syndrome (OSAS) and overlap syndrome (OS): The role of nocturnal hypoxemia and CPAP compliance 128
Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2? 128
Obstructive Sleep Apnea Worsens Progression-Free and Overall Survival in Human Metastatic Colorectal Carcinoma 120
Impact of CT Scan Phenotypes in Clinical Manifestations, Management and Outcomes of Hospitalised Patients With COVID-19 115
Exhaled Breath Temperature Home Monitoring to Detect NSCLC Relapse: Results from a Pilot Study 106
Impact of CT Scan Phenotypes in Clinical Manifestations, Management and Outcomes of Hospitalised Patients with COVID-19 105
Effect of Hypoxia-Induced Micro-RNAs Expression on Oncogenesis 104
Imaging profile after treatment with Tocilizumab in COVID-19: a case series 104
A Report on a Targeted Screening Population for Alpha-1-Antitrypsin Deficiency (AATD) in Central-Southern Italy 100
Knowledge of telemedicine in a sleep clinic during the COVID-19 pandemic by a phone survey 95
Lung Ultrasound in the Diagnosis of COVID-19 Pneumonia: Not Always and Not Only What Is COVID-19 “Glitters” 95
Exploring phenotypes to improve long-term mortality risk stratification in obstructive sleep apnea through a machine learning approach: an observational cohort study 95
Machine learning-based prediction of adherence to continuous positive airway pressure (CPAP) in obstructive sleep apnea (OSA) 94
Could transthoracic ultrasound be useful to suggest a small airways disease in severe uncontrolled asthma? 90
Obstructive Sleep Apnoea-Hypopnoea Syndrome (OSAHS): state of the art 89
Clinical Remission in Patients Affected by Severe Eosinophilic Asthma on Dupilumab Therapy: A Long-Term Real-Life Study 87
How Are We Handling the Post-COVID Patients? The Dance of Uncertainties 86
A preliminary report of gender differences in residual sleepiness of CPAP-treated obstructive sleep apnea 85
Exhaled Breath Temperature Home Monitoring to Detect NSCLC Relapse: Results from a Pilot Study 85
Clinical Features of SARS-COV-2 Infection After Full Vaccination in Health Care Workers of a COVID Hospital 84
Efficacy of prone positioning in COVID-19 pneumonia according to radiological phenotypes 84
Breath and Sputum Analyses in Asthmatic Patients: An Overview 82
Crisis resource management applied to non-intubated video-assisted thoracoscopic surgery 80
Adaptive immunity in different CT patterns of active tuberculosis and possible variability according to patients' geographic provenience 77
Interstitial lung diseases with concomitant lung cancer: a data mining approach revealing a complex condition with gender- and immune-associated specific implications 77
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 75
Controlling Nutritional Status Score as a Predictor for Chronic Obstructive Pulmonary Disease Exacerbation Risk in Elderly Patients 74
MiRNA and Exosomal miRNA as New Biomarkers Useful to Phenotyping Severe Asthma 74
The CORE syndrome: an overlap of severe asthma, obstructive sleep apnea, rhinosinusitis, and esophageal reflux 73
Usefulness of sleep events detection using a wrist worn peripheral arterial tone signal device (WatchPAT™) in a population at low risk of obstructive sleep apnea 72
Machine Learning and BMI Improve the Prognostic Value of GAP Index in Treated IPF Patients 71
Bayesian Integration of Bronchoalveolar Lavage miRNAs and KL-6 in Progressive Pulmonary Fibrosis Diagnosis 71
Nano-into-Micro systems for delivery of anti-infl ammatory agents in human respiratory epithelial cell models of cystic fibrosis 70
Local Anesthetic Thoracoscopy: A Focus on Indications, Techniques and Complications 70
Searching for airways biomarkers useful to identify progressive pulmonary fibrosis 70
EVs-miRNA: The New Molecular Markers for Chronic Respiratory Diseases 69
Utility of Clustering in Mortality Risk Stratification in Pulmonary Hypertension 69
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 68
Three endobronchial white trees in a patient with mild hemoptysis: A rare case of broncholithiasis 68
Gender Differences Are a Leading Factor in 5-Year Survival of Patients with Idiopathic Pulmonary Fibrosis over Antifibrotic Therapy Reduction 68
Switch of Nocturnal Non-Invasive Positive Pressure Ventilation (NPPV) in Obstructive Sleep Apnea (OSA) 67
Long-Term Clinical Remission on Benralizumab Treatment in Severe Eosinophilic Asthma: A Four-Year Real-Life Study 67
Intermittent Hypoxia Mediates Cancer Development and Progression Through HIF-1 and miRNA Regulation 66
Obstructive Sleep Apnea: A Look towards Micro-RNAs as Biomarkers of the Future 66
Usefulness of sleep events detection using a wrist worn peripheral arterial tone signal device (WatchPAT™) in a population at low risk of obstructive sleep apnea 66
Real life experience of molnupiravir as a treatment of SARS-CoV-2 infection in vaccinated and unvaccinated patients: a letter on its effectiveness at preventing hospitalization 65
Biomolecular Actions by Intestinal Endotoxemia in Metabolic Syndrome 65
Clinical Evaluation and Management of Overlap Syndrome (OS) and Obesity Hypoventilation Syndrome (OHS) 64
Management options for excessive daytime sleepiness in patients with obstructive sleep apnea 63
Inhaled Medications in Chronic Respiratory Diseases: Analysis of Real-Life Use in Puglia (Apulia), Italy 61
MiRNA expression affects survival in patients with obstructive sleep apnea and metastatic colorectal cancer 60
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 59
Low-intensity rehabilitation in persistent post COVID-19 dyspnoea: the value of Spa health resort as appropriate setting 59
The Burden of Respiratory Alterations during Sleep on Comorbidities in Obstructive Sleep Apnoea (OSA) 59
Role of BAL and Serum Krebs von den Lungen-6 (KL-6) in Patients with Pulmonary Fibrosis 57
Causes, management and treatment of empyema 57
Baseline plethysmographic signal of arterial pulse during polysomnography: a potential insight into venous return and its clinical implications 55
Disease stage-related survival in idiopathic pulmonary fibrosis patients treated with nintedanib and pirfenidone: An exploratory study 55
Anxiety and depressive symptoms on continuous positive airway pressure: long-term adherence in patients with sleep apnea syndrome 54
Electronic Nose Analysis of Exhaled Breath Volatile Organic Compound Profiles during Normoxia, Hypoxia, and Hyperoxia 53
Sex and gender differences during the lung lifespan: unveiling a pivotal impact 53
Management of CPAP Follow-up by Telemonitoring in Obstructive Sleep Apnea: The PROTEUS Project 52
Multidimensional Approach to Phenotype Obstructive Sleep Apnea (OSA): Integrating Biological, Clinical and Computational Insights 51
Do We Really Need to Treat over 80-Year-Old Patients Affected by IPF? 49
The role of microsleeps to estimate sleepiness at the wheel and near-miss accidents in obstructive sleep apnea 47
Anti-Inflammatory Effect of Novel Inhalable Iloprost Formulations in Primary Nasal Epithelial Cells from Cystic Fibrosis Patients 44
ERS International Congress 2023: highlights from the Sleep Disordered Breathing Assembly 43
Factors Associated With One-Year Mortality in Hospitalised Patients With Exacerbated Bronchiectasis 43
Resolution of daytime and night-time respiratory symptoms but persistent sleep apnea in severe asthma with the add-on of benralizumab 39
Multidimensional phenotyping to distinguish among distinct obstructive sleep apnea, chronic obstructive pulmonary disease, and overlap syndrome phenotypes 36
ANTI-INFLAMMATORY EFFECTS OF INHALABLE ILOPROST FORMULATIONS IN PRIMARY HUMAN CYSTIC FIBROSIS NASAL EPITHELIAL CELLS 33
The Involvement of MicroRNAs in Innate Immunity and Cystic Fibrosis Lung Disease: A Narrative Review 23
Iloprost-loaded inhalable Nano into Micro (NiM) formulations for treating hyper-inflammation in a pre-clinical model of cystic fibrosis airway epithelial cells 21
Comparative effects of MAD and CPAP on heart rate in obstructive sleep apnea 21
OSA Endotyping as Targets for Treatment. How Far Have We Come? 17
Obstructive sleep apnea as a modifier of endocrine toxicities associated with immune checkpoint inhibitors in lung cancer 15
Redefining insomnia as a disregulated adaptive response in modern society 14
Ru-SATED scale and Sleep Health Index: A systematic review of two leading multidimensional sleep health measures and frameworks across the globe 14
Distinct Hypoxemic Profiles of Obstructive Sleep Apnea in Southern Italy: The Living with OSA and CPAP Study 11
Asthma Awareness Questionnaire: Development, Psychometric Validation, and Extent 10
The Role of DLNO in the Functional Assessment of Patients with Idiopathic Pulmonary Fibrosis 10
Physical activity phenotypes in obstructive sleep apnea: real-world data 8
Totale 5.498
Categoria #
all - tutte 26.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202262 0 0 0 2 9 0 4 6 4 13 3 21
2022/2023486 20 20 21 24 44 51 5 45 220 4 9 23
2023/2024191 33 5 8 2 9 37 27 13 6 3 1 47
2024/20251.271 25 23 46 20 38 131 176 107 240 175 157 133
2025/20262.895 203 223 326 314 124 147 513 326 176 230 169 144
2026/2027569 73 248 230 18 0 0 0 0 0 0 0 0
Totale 5.498